Literature DB >> 25817840

Why acute unilateral vestibular cortex lesions mostly manifest without vertigo.

Marianne Dieterich1, Thomas Brandt2.   

Abstract

OBJECTIVES: The aim of the current study was, first, to determine the critical causative vestibular areas that in exceptional cases manifest with transient vertigo or dizziness in acute strokes of the middle cerebral artery, and second, to try to explain why in most cases unilateral lesions of these areas manifest without vertigo.
METHODS: We determined the ischemic areas of the 10 published cases by overlapping the CT/MRI lesions and attributed them to the temporoparietal vestibular network.
RESULTS: These overlap areas were located either in the posterior retroinsular cortex (n = 8), i.e., the parieto-insular vestibular cortex, or the separate parietal vestibular cortex (n = 2).
CONCLUSION: Thus, rare vestibular cortical vertigo is mostly elicited by acute lesions of the core region of the retroinsular vestibular network. However, the more interesting question is related to the lack of cortical vertigo when this area is affected. We propose a concept to explain how the unaffected opposite hemisphere can suppress vertigo. This is based on visual-vestibular interaction for motion perception and orientation. It is the hemisphere in which vestibular and visual inputs are in agreement, which is the more reliable and determines the global perception of body orientation and motion.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 25817840     DOI: 10.1212/WNL.0000000000001501

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Electrical brain stimulation of the parietal lobe impairs the perception of verticality.

Authors:  O Kremmyda; V Kirsch; S Bardins; H Lohr; C Vollmar; S Noachtar; M Dieterich
Journal:  J Neurol       Date:  2019-05-10       Impact factor: 4.849

Review 2.  The dizzy patient: don't forget disorders of the central vestibular system.

Authors:  Thomas Brandt; Marianne Dieterich
Journal:  Nat Rev Neurol       Date:  2017-04-21       Impact factor: 42.937

Review 3.  [Vertigo and dizziness in the emergency room].

Authors:  A Zwergal; K Möhwald; M Dieterich
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

4.  Evaluating the rare cases of cortical vertigo using disconnectome mapping.

Authors:  Julian Conrad; Rainer Boegle; Ria Maxine Ruehl; Marianne Dieterich
Journal:  Brain Struct Funct       Date:  2022-07-15       Impact factor: 3.748

5.  Impaired Duration Perception in Patients With Unilateral Vestibulopathy During Whole-Body Rotation.

Authors:  Eunjin Kwon; Ju-Young Lee; Jung-Mi Song; Hyo-Jung Kim; Jong-Hee Lee; Jeong-Yoon Choi; Ji-Soo Kim
Journal:  Front Integr Neurosci       Date:  2022-06-03

Review 6.  [Neuro-otology: at the borders of ear and brain].

Authors:  A Zwergal; V Kirsch; J Gerb; J Dlugaiczyk; S Becker-Bense; M Dieterich
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

7.  Central vestibular disorder due to ischemic injury on the parieto-insular vestibular cortex in patients with middle cerebral artery territory infarction: Observational study.

Authors:  Sang Seok Yeo; Sung Ho Jang; Jung Won Kwon
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Why acute unilateral vestibular midbrain lesions rarely manifest with rotational vertigo: a clinical and modelling approach to head direction cell function.

Authors:  Marianne Dieterich; Stefan Glasauer; Thomas Brandt
Journal:  J Neurol       Date:  2018-03-16       Impact factor: 4.849

Review 9.  Perception of Upright: Multisensory Convergence and the Role of Temporo-Parietal Cortex.

Authors:  Amir Kheradmand; Ariel Winnick
Journal:  Front Neurol       Date:  2017-10-25       Impact factor: 4.003

Review 10.  Ten problems and solutions when predicting individual outcome from lesion site after stroke.

Authors:  Cathy J Price; Thomas M Hope; Mohamed L Seghier
Journal:  Neuroimage       Date:  2016-08-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.